Abstract
Arsenic methylation is catalyzed by the enzyme As(III)-S-adenosylmethionine methyltransferase (AS3MT or ArsM) that transfers up to three methyl groups from SAM to As(III), producing CH 3 As(III), (CH 3) 2MAs(III) and the nontoxic gaseous product (CH 3) 3MAs(III). In liver AS3MT methylates arsenic, which is excreted in urine. This biotransformation is thought to activate arsenic into a carcinogen. A thermophilic orthologue of human AS3MT was crystallized, and its x-ray crystal structure solved to 1.6 å with bound SAM or As(III). Our data support a pathway of methylation in which GSH conjugates are preferred substrates, and arsenic remains trivalent throughout the catalytic cycle. The location of polymorphisms were mapped onto a homology model of human AS3MT, giving insight into their biochemical effects. Finally, a new gene/enzyme that demethylates methylarsenicals was cloned/purified and characterized.
Original language | English |
---|---|
Title of host publication | Understanding the Geological and Medical Interface of Arsenic, As 2012 - 4th International Congress |
Subtitle of host publication | Arsenic in the Environment |
Pages | 185-188 |
Number of pages | 4 |
Publication status | Published - 16-08-2012 |
Event | 4th International Congress on Arsenic in the Environment, As 2012 - Cairns, QLD, Australia Duration: 22-07-2012 → 27-07-2012 |
Conference
Conference | 4th International Congress on Arsenic in the Environment, As 2012 |
---|---|
Country/Territory | Australia |
City | Cairns, QLD |
Period | 22-07-12 → 27-07-12 |
All Science Journal Classification (ASJC) codes
- Environmental Chemistry
- Pollution